| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | CA2731513A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/03/2010 | EP2148667A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7654957 Apparatus for physical measurements of the eye |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011622A2 Ophthalmic gallium compositions and methods of their use |
| 01/28/2010 | WO2010011609A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011605A2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011466A2 Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2010011119A1 Ophthalmic solution for corneal enlargement |
| 01/28/2010 | WO2010010939A1 Prophylactic or therapeutic agent for age-related macular degeneration |
| 01/28/2010 | WO2010010715A1 Stable aqueous solution composition containing sulfonamide compound |
| 01/28/2010 | WO2010010702A1 Prophylactic or therapeutic agent for axial myopia |
| 01/28/2010 | WO2010010365A1 Polyunsaturated fatty acids for improving vision |
| 01/28/2010 | WO2010010208A1 siRNA AND shRNA FOR THE PRODUCTION OF DRUGS FOR HIGH INTRAOCULAR PRESSURE |
| 01/28/2010 | WO2009136396A3 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022661 Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022623 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 01/28/2010 | US20100022563 Phosphodiesterase inhibitor treatment |
| 01/28/2010 | US20100022517 Ophthalmic formulation of rho kinase inhibitor compound |
| 01/28/2010 | US20100022473 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 01/28/2010 | US20100022472 Liquid, eye-instillable preparations comprising sodium hyaluronate |
| 01/28/2010 | US20100022471 Oral Moisturizer for Alleviating Dry Mouth |
| 01/28/2010 | US20100022465 Method of treating blepharitis |
| 01/28/2010 | US20100022458 Methods for treating acute acoustic trauma |
| 01/28/2010 | US20100021562 Self preserved aqueous pharmaceutical compositions |
| 01/28/2010 | US20100021561 Self-preserved aqueous pharmaceutical compositions |
| 01/28/2010 | US20100021493 Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositons containing the same |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021416 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | CA2731769A1 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731766A1 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731271A1 Stable aqueous solution composition containing sulfonamide compound |
| 01/27/2010 | EP2146948A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| 01/27/2010 | EP2146737A1 Copolymer synthesized from modified glycosaminoglycan, gag, and an anhydride functionalized hydrophobic polymer |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP2146726A1 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions |
| 01/27/2010 | EP1732574B1 Use of o-atp for the treatment of diseases involving angiogenesis |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584332C Eye-drops preparations containing tetrandrine and its application for preparing medicine therewith |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652038 Methods of reducing angiogenesis |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/21/2010 | WO2010009034A2 Method for treating atrophic age related macular degeneration |
| 01/21/2010 | WO2010008995A2 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 01/21/2010 | WO2010008775A1 Aminopyridopyrazinone derivatives for treating neurodegenerative diseases |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2009091764A3 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016395 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 01/21/2010 | US20100016336 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/21/2010 | US20100016281 Pyrimidine compounds as serotonin receptor modulators |
| 01/21/2010 | US20100016267 Pharmaceutical compositions for administraton to a sinus |
| 01/21/2010 | US20100016256 Taxane Compounds for Treating Eye Disease |
| 01/21/2010 | US20100016219 Ophthalmic compositions containing solubilized cyclosporin |
| 01/21/2010 | US20100016218 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015263 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 01/21/2010 | US20100015229 Pharmaceutical compositions |
| 01/21/2010 | US20100015178 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/21/2010 | US20100015158 Method for treating atrophic age related macular degeneration |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015065 Compositions for food, process for producing the same, and functional foods and drinks containing the same |
| 01/21/2010 | CA2731270A1 Method for treating atrophic age related macular degeneration |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730847A1 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/20/2010 | EP1828148B1 Triazole substituted aminobenzophenone compounds |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1218027B1 Composition for stabilizing corneal tissue during or after orthokeratological lens wear |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN100582121C 胸腺素β4衍生物及其应用 Thymosin β4 derivative and its applications |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |